Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for COCP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 -1.093M
September 30, 2025 -4.540M
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.1747M
September 30, 2023 -0.1047M
June 30, 2023 -4.110M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 1.024M
September 30, 2021 0.1777M
June 30, 2021 -36.77M
March 31, 2021 -2.072M
December 31, 2020 -6.048M
September 30, 2020 -15.94M
June 30, 2020 1.163M
Date Value
March 31, 2020 -16.61M
December 31, 2019 -2.730M
September 30, 2019 0.0284M
June 30, 2019 -0.0085M
March 31, 2019 -3.928M
December 31, 2018 0.2312M
September 30, 2018 -0.1781M
June 30, 2018 -7.547M
March 31, 2018 -0.184M
December 31, 2017 0.2207M
September 30, 2017 -0.1483M
June 30, 2017 -3.142M
March 31, 2017 0.00
December 31, 2016 0.2481M
September 30, 2016 -3.740M
June 30, 2016 0.0081M
March 31, 2016 -5.007M
December 31, 2015 -0.0972M
September 30, 2015 0.7266M
June 30, 2015 -3.854M
March 31, 2015 -11.83M
December 31, 2014 0.1135M
September 30, 2014 -0.0299M
June 30, 2014 -0.0634M
March 31, 2014 -2.769M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
CNBX Pharmaceuticals, Inc. 0.00
GB Sciences, Inc. --
Arvinas, Inc. -0.50M
Fulcrum Therapeutics, Inc. -0.356M
Definium Therapeutics, Inc. -758.70M